Emma Laycock
Emma Laycock is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She is a Policy Officer at the Academy of Medical Sciences and previously studied for a PhD in Stem Cell Biology at University College London's Cancer Institute, modelling how childhood leukaemia develops in utero. Prior to this, she worked as a Journal Development Editor at BioMed Central, responsible for a cluster of biotechnology journals. She originally studied Biomedical Science at the University of Warwick, and her degree included an intercalated year at the National Institute for Biological Standards and Control and a summer placement at the National University of Ireland in Galway, studying whooping cough and water contaminants respectively. She tweets as @EmmaVLaycock
BioNews Comment articles written by Emma Laycock:
| Science marches on: key scientific developments in embryo research |
|---|
| 7 January 2019 - by Emma Laycock |
| 'Science marches on' was the third session of the Progress Educational Trust (PET)'s Annual Conference 'Make Do or Amend: Should We Update UK Fertility and Embryo Law?'. The session focused on the key scientific developments within embryo research asking: where are we now, what can we learn from past battles and, most importantly, where are we going?... [Read More] |
BioNews Review articles written by Emma Laycock:
| Podcast Review: CRISPR Updated |
|---|
| 27 March 2017 - by Emma Laycock |
| Radiolab explores the science, the uses and the ethics of CRISPR in this podcast that was two years in the making... [Read More] |
BioNews News articles written by Emma Laycock:
| Blood test detects ovarian cancer two years earlier |
|---|
| 27 August 2019 - by Emma Laycock |
| Scientists have developed a blood test that may be able to detect ovarian cancer up to two years earlier than other methods... [Read More] |
| New blood test could help diagnose ovarian cancer |
| 24 June 2019 - by Emma Laycock |
| Scientists have discovered a set of biomarkers in the blood that could indicate ovarian cancer, which could be used to help diagnose the disease... [Read More] |
| Stress during military conflict lowers sperm quality |
| 11 June 2018 - by Emma Laycock |
| Scientists in Israel have linked prolonged stress during outbreaks of Israeli-Palestinian conflict with lowered sperm quality in Israeli men... [Read More] |
| Painkillers in pregnancy may affect offspring's fertility |
| 23 April 2018 - by Emma Laycock |
| Taking painkillers during pregnancy could affect the future fertility of the fetus, suggests research on human tissue and in mice... [Read More] |
| Human trophoblast stem cells cultured for first time |
| 29 January 2018 - by Emma Laycock |
| Scientists in Japan have cultured human trophoblast stem cells, which form the placenta, for the first time... [Read More] |
| Large volumes of stem cells collected during caesareans |
| 11 December 2017 - by Emma Laycock |
| An efficient method to collect amniotic fluid rich in stem cells during caesarean sections has been developed by scientists in Sweden... [Read More] |
| 'CRISPR-Gold' repairs muscular dystrophy gene in mouse model |
| 9 October 2017 - by Emma Laycock |
| Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR-Cas9... [Read More] |
| Vitamin C slows leukaemia in mice by tweaking key gene |
| 21 August 2017 - by Emma Laycock |
| High doses of vitamin C may help fight certain leukaemias by boosting the activity of a particular gene, suggests a new study... [Read More] |
| High-dose paracetamol changes brains of male fetuses in mice |
| 3 July 2017 - by Emma Laycock |
| The daily use of paracetamol in pregnant mice affects the brain development and behaviour of male offspring, according to researchers in Denmark... [Read More] |
| CRISPR genome editing eliminates HIV in mice |
| 8 May 2017 - by Emma Laycock |
| US scientists have used CRISPR gene-editing to remove HIV DNA from the genomes of living animals, eliminating further infection. |
